May 8
Currus Biologics: a tale of perseverance, persistence and patience
Read more
Vale Rob Knowles
The Honourable Rob Knowles AO, a prominent former Victorian Health Minister, passed away on 29 April 2026 at the age of 78. He was a director on the board of Brandon BioCatalyst from December 2019 until April 2025. Rob made significant contributions to the health and life sciences sector and to the broader Australian health system over many years.
Brandon Capital extends its heartfelt condolences to Mr Knowles’ wife Carmel, and to his children, grandchildren, extended family and friends.
Brandon BioCatalyst is the largest life science investment fund in Australia and New Zealand. We are a unique collaboration between major Australian superannuation funds, CSL, the Australian and New Zealand governments, Australian state governments and more than 50 leading medical research institutes and research hospitals.
Learn more about who we areA clinical stage company developing treatment for hot flashes in cancer survivors undergoing endocrine therapy
View ProjectDeveloping disease-modifying mitochondrial therapeutics for neurodegenerative disorders
View ProjectDeveloping the next generation of CAR-T cell therapies to treat solid cancers
View ProjectCombining non-opioid analgesics and biopolymers to deliver weeks of localised pain management
View ProjectUnlocking the potential of N-myristoyltransferase (NMT) to develop precision medicines for a range of diseases including cancer and viral infections
View ProjectGlyscend is developing novel non-absorbable polymers that are orally-delivered for the treatment of Type 2 Diabetes.
View ProjectThe Malaghan Institute of Medical Research is New Zealand’s leading independent biomedical research institute, with a history spanning over five decades. The Institute’s research centers on the immune system, and how it may be harnessed to treat human disease. Pioneering research programmes explore fields of immunotherapy such as cancer, asthma and allergy, infectious diseases, gut health and brain health.
ViewThe Brain Health Research Centre is one of the pre‐eminent neuroscience centres in NZ. It consists of more than 40 research groups (academic & clinical), plus their research staff and students across a number of schools and campuses in the Divisions of Health Sciences and Sciences at the University of Otago. The mission of the Brain Health Research Centre (BHRC) is to support excellent, international quality research at the University of Otago, aimed at understanding the mechanisms of brain health, disease and repair, including the development of new treatments for neurological disorders.
Brandon BioCatalyst is innovation in action: We provide a path for taking medical science from conception into the real world.
Our Venture capital model is unique. We don’t simply provide investment, we partner with entrepreneurs to create businesses, run companies and everything necessary to ensure our investments succeed.
Learn moreOncoRes Medical today announced it has closed an AUD $27M private funding round (‘the Funding round’) to progress clinical development and regulatory milestones for its Quantitative Micro-Elastography (QME) Imaging System, Elora™.
Read morePolyActiva Chief Strategy Officer Vanessa Waddell on Raising, Rejection, and the Road Ahead
Read moreScience: The World’s Shared Language That Carried One Founder Across Continents
Read more